These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 24753025)

  • 1. Reply: To PMID 23907815.
    Park NH; Jung SW; Shin ES; Chung YH
    Hepatology; 2014 Dec; 60(6):2132-4. PubMed ID: 24753025
    [No Abstract]   [Full Text] [Related]  

  • 2. Prognostic impact of telomere maintenance gene polymorphisms in hepatocellular carcinoma patients: some issues need to be clarified.
    Liu F; Wang WT; Wei YG; Li B
    Hepatology; 2014 Dec; 60(6):2131-2. PubMed ID: 24753044
    [No Abstract]   [Full Text] [Related]  

  • 3. Prognostic impact of telomere maintenance gene polymorphisms on hepatocellular carcinoma patients with chronic hepatitis B.
    Jung SW; Park NH; Shin JW; Park BR; Kim CJ; Lee JE; Shin ES; Kim JA; Chung YH
    Hepatology; 2014 May; 59(5):1912-20. PubMed ID: 23907815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship of single nucleotide polymorphism, environmental factors and the hereditary susceptibility of hepatocellular carcinoma].
    Ji L; Yu H
    Wei Sheng Yan Jiu; 2009 Mar; 38(2):233-7. PubMed ID: 19408671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytokine polymorphisms and hepatocellular carcinoma: to B or not to B.
    Chung RT
    Cancer; 2005 Feb; 103(4):654-6. PubMed ID: 15641028
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of STAT3 rs1053004 single nucleotide polymorphism in patients with chronic hepatitis B and hepatocellular carcinoma.
    Fatemipour M; Arabzadeh SAM; Molaei H; Geramizadeh B; Dabiri S; Fatemipour B; Vahedi SM; Malekpour Afshar R
    Cell Mol Biol (Noisy-le-grand); 2017 Dec; 63(12):45-50. PubMed ID: 29307341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma pathogenesis: does PPAR alpha polymorphism have a role in hepatocarcinogenesis associated with HBV and HCV infections?
    Akkiz H
    Turk J Gastroenterol; 2008 Dec; 19(4):231-3. PubMed ID: 19119480
    [No Abstract]   [Full Text] [Related]  

  • 8. Telomeric 3' overhangs in chronic HBV-related hepatitis and hepatocellular carcinoma.
    Lee JE; Oh BK; Choi J; Park YN
    Int J Cancer; 2008 Jul; 123(2):264-272. PubMed ID: 18449889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of telomere length in peripheral leukocytes with chronic hepatitis B and hepatocellular carcinoma.
    Ma Q; Cai J; Cai Y; Xu Y; Chang F; Xu L; Zhang G; Guo X
    Medicine (Baltimore); 2016 Sep; 95(39):e4970. PubMed ID: 27684844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Kim YJ; Lee HS
    Intervirology; 2005; 48(1):10-5. PubMed ID: 15785084
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of polymorphism in microRNA 604 with susceptibility to persistent hepatitis B virus infection and development of hepatocellular carcinoma.
    Cheong JY; Shin HD; Cho SW; Kim YJ
    J Korean Med Sci; 2014 Nov; 29(11):1523-7. PubMed ID: 25408584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significant SNPs Related to Telomere Length and Hepatocellular Carcinoma Risk in Chronic Hepatitis B Carriers.
    Mohamadkhani A; Pourasgari M; Poustchi H
    Asian Pac J Cancer Prev; 2018 Mar; 19(3):585-590. PubMed ID: 29579787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. STAT4 gene polymorphism and risk of chronic hepatitis B-induced hepatocellular carcinoma.
    Zhao X; Jiang K; Liang B; Huang X
    Cell Biochem Biophys; 2015 Jan; 71(1):353-7. PubMed ID: 25178516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic hepatitis B in hepatocarcinogenesis.
    Park NH; Song IH; Chung YH
    Postgrad Med J; 2006 Aug; 82(970):507-15. PubMed ID: 16891440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.
    Han Y; Pu R; Han X; Zhao J; Li W; Yin J; Zhang Y; Shen Q; Xie J; Zhang Q; Jiang S; Li J; Zhang H; Wang H; Cao G
    Liver Int; 2014 May; 34(5):728-36. PubMed ID: 24118778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MDM2 and p53 polymorphisms are associated with the development of hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
    Yoon YJ; Chang HY; Ahn SH; Kim JK; Park YK; Kang DR; Park JY; Myoung SM; Kim DY; Chon CY; Han KH
    Carcinogenesis; 2008 Jun; 29(6):1192-6. PubMed ID: 18390844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genome-wide association study: new genetic insights into HBV/HCV-related hepatocellular carcinoma genomes.
    Zhu H; Wu J; Shen X
    Scand J Gastroenterol; 2017 Feb; 52(2):209-215. PubMed ID: 27797287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Relationship Between Single-Nucleotide Polymorphisms, the Expression of DNA Damage Response Genes, and Hepatocellular Carcinoma in a Polish Population.
    Krupa R; Czarny P; Wigner P; Wozny J; Jablkowski M; Kordek R; Szemraj J; Sliwinski T
    DNA Cell Biol; 2017 Aug; 36(8):693-708. PubMed ID: 28598207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of a variant in MIR 196A2 with susceptibility to hepatocellular carcinoma in male Chinese patients with chronic hepatitis B virus infection.
    Qi P; Dou TH; Geng L; Zhou FG; Gu X; Wang H; Gao CF
    Hum Immunol; 2010 Jun; 71(6):621-6. PubMed ID: 20188135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Recent advances in basic research on primary liver cancer].
    Wang HY; Wu MC
    Zhonghua Gan Zang Bing Za Zhi; 2004 Nov; 12(11):641-2. PubMed ID: 15623367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.